ClinicalTrials.gg
Status unknownNCT04672694Updated Jan 12, 2021

Effects of Intraoperative Vagal Block on Reducing the Postoperative Cough After Thoracic Surgery

An interventional study of Vagus nerve block and No vagus nerve block in Cough, Thoracic Surgery and Nerve Block, sponsored by Severance Hospital. Status unknown at 1 site in Korea, Republic of. Open to participants aged 19 Years to 80 Years. Per ClinicalTrials.gov, last updated 2021-01-12.

Sponsored by Severance Hospital · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Jan 2021), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
19 Years to 80 Years
Sex
All
01

Study summary

Randomized controlled study to investigate the role of intraoperative vagal nerve block for preventing the postoperative cough in patients who received the pulmonary resection for lung cancer

Read the detailed description

The standard treatments for early primary lung cancer are surgical treatments (lobectomy and lymph node resection). The usual mortality rate of lung cancer surgery is 1-2%, and the incidence of complications is reported to be about 20%. In addition to these deaths and complications, there are frequent sequelae such as reduction of pulmonary function reduction and cough. According to a cross section study of 240 patients who underwent lung cancer surgery, about 30% of patients complained of cough after surgery for one year after surgery, and 50% of patients complained of cough after one year. After the pulmonary resection of lung cancer, chronic coughs are the main cause of lowering the quality of life of patients after lung surgery. Several studies have reported the risk factors of cough after lung cancer surgery, and it is known that there is a relationship between mediastinal lymph node resection and accompanying gastric-esophageal gastric acid reflux.

According to anatomy and physiology studies of coughs, coughing occurs due to stimulation of vagus nerves, which is a type of reflex to protect the respiratory tract from harmful stimuli from the outside. Cough cough is known to occur when c-fibers are stimulated, especially at the end of the vagus nerve. Cough reflex-related circuits from c-fiber to brain are generated, and then coughing is reported in smaller stimuli. The end of the vagus nerves in the bronchial area can be damaged by the mediastinal lymph nodes dissection during lung cancer surgery and it can lead to c-fiber stimulation and finally form the nerve circuit which can lead to chronic cough.

Recently, awake pulmonary resection (awakening surgery) has been performed in several countries. Normally, sleep anesthesia gas itself is depleted of vagus nerve function and does not cause cough reflex during surgery, but when operated in a waking state, coughing caused by vagus nerve stimulation may occur and dangerous situations may occur during surgery, so it is reported that vagus nerve block is performed at the start of surgery. These vagus nerve blocks are known to prevent cough reflex during awakening surgery and enable surgery to be performed stably. However, it is not yet known whether these vagus nerve block can reduce acute and chronic cough after surgery. In this study, we investigated whether vagus nerve block during surgery could reduce coughing after surgery in patients who underwent general anesthesia lung cancer surgery.

02

Conditions studied

  • Cough
  • Thoracic Surgery
  • Nerve Block

Browse trials for

03

In context

Cough

427 studies on the registry are indexed under Cough; 67 are open to participants now.

This study's planned enrollment of 100 is above the median of 80 across 319 interventional studies indexed under Cough.

Browse Cough studies →

Lead sponsor

Severance Hospital is the lead sponsor of 51 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • ' physical status class Ⅲ
  • Diagnosed with non-small cell lung cancer with clinical stage of I-IIIA
  • Planned to undergo segmentectomy or lobectomy with mediastinal lymph node dissection

Exclusion criteria

Exclusion Criteria:

  • chronic cough symptoms before surgery; a chronic cough (a cough lasting more than eight weeks)
  • chemotherapy or chemoradiotherapy prior to surgery
  • current smoker (patient should quit smoking at least 2 weeks before surgery)
  • previously diagnosed with airway disease prior to surgery
  • previously diagnosed with asthma prior to surgery
  • patients with nervous system defects or psychiatric problems
  • patients with severe cardiovascular disease, hepatological, or renal failure
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
100 participants (estimated)

Study arms

  • Active comparator
    VNB (vagus nerve block)

    Vagus nerve block

    Procedure: Vagus nerve block

  • Placebo comparator
    Control

    No vagus nerve block

    Procedure: No vagus nerve block

Interventions

  • ProcedureVagus nerve block

    Ropivacine 0.75% 2mL will be injected two times around the vagus nerve (just below the bifurcation of recurrent laryngeal nerve); one before starting the surgical resection of lung including complete mediasitnal lymph node dissection and one at the end of operation.

  • ProcedureNo vagus nerve block

    No vagus nerve block will be conducted during the surgery.

06

What researchers measure

Primary outcomes

  1. Cough score

    The cough score is a two-part questionnaire referring to a symptoms during the day and night time. The response scale captures cough frequency, intensity and overall impact.

    Time frame: 6 months after surgery

Secondary outcomes

  1. COAT, Cough Assessment Test

    The COAT is a short, simple questionnaire that assesses cough frequency, limitation on daily activities, sleep disturbance, fatigue and hypersensitivity to irritants in recent 1 week. It consists of five items, each with a 5-point differential scale (0-4), constituting a 0-20-point total scale.

    Time frame: 6 months after surgery

  2. Cough numeric rating scales (NRS)

    The cough NRS range from 0 (no cough at all) to 10 (maximal cough).

    Time frame: 6 months after surgery

  3. Leicester cough questionnaire

    LCQ is a validated self-reporting quality of life measures of cough in recent 2 weeks. It consists of 19 items with a 7 point likert response scale (range from 1 to 7) and it takes less than 5 minutes to complete.

    Time frame: 6 months after surgery

07

Study locations

1 of 1 sites recruiting
  • Yonsei Severance Hospital
    Seoul, Korea, Republic of
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2020 (actual). Primary completion is estimated for Nov 2022, 23 months after the start.

Of 78 non-industry interventional studies with no phase under Cough, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 38. This study's planned 23 months is above that.

Counting every sponsor, half of 86 studies reached it within 15 months; a quarter within 6 and three quarters within 38.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 6, 2020
First posted
Dec 17, 2020
StartActual
Dec 29, 2020
Primary completionEst.
Nov 2022
CompletionEst.
Nov 2023
Last update
Jan 12, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 12, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04672694
Lead sponsor
Severance Hospital
Responsible party
Seong Yong Park (Associate Professor, Severance Hospital) — Principal investigator
First posted
Dec 17, 2020
Start date
Dec 29, 2020
Primary completion
Nov 2022 (estimated)
Completion
Nov 2023 (estimated)
Last update
Jan 12, 2021

Study contacts

Seong Yong Park
Contact
SYPARKCS@yuhs.ac
82-2-2228-2142
Seong Yong Park
principal investigator · Severance Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion